Summary & Overview
CPT 99184: Neonatal Therapeutic Hypothermia with Esophageal Temperature Monitoring
CPT code 99184 represents therapeutic hypothermia for critically ill neonates, typically applied after perinatal hypoxic events such as hypoxic–ischemic encephalopathy (HIE). The procedure involves controlled reduction of head or body temperature and continuous temperature monitoring using an esophageal probe. This intervention is clinically significant because timely, protocol-driven cooling can influence neurologic outcomes in selected neonates and is performed in high-acuity inpatient neonatal settings.
Key national payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service setting, payer coverage considerations, common modifiers associated with claims, and the implications for billing workflows in neonatal intensive care units. The publication also outlines typical documentation elements tied to patient selection and monitoring that support medical necessity determinations.
This summary provides clinicians, coders, and billing managers with the essential context for CPT code 99184, including where the service is performed, why it matters clinically, and what to expect from payer coverage considerations. Data not available in the input are noted where applicable in detailed sections.
Billing Code Overview
CPT code 99184 describes selective head or body temperature reduction (therapeutic hypothermia) for a critically ill neonate, applied after careful consideration of clinical selection criteria. The service includes continuous temperature monitoring using an esophageal probe and is performed when a neonate experiences hypoxic events such as perinatal hypoxic–ischemic encephalopathy (HIE).
Service type: Neonatal therapeutic hypothermia / temperature management procedure
Typical site of service: Neonatal intensive care unit (NICU) or other inpatient critical care settings where continuous esophageal temperature monitoring and intensive neonatal support are available.
Clinical & Coding Specifications
Clinical Context
A term neonate is born following a prolonged, complicated delivery with evidence of perinatal asphyxia: low Apgar scores at 1 and 5 minutes, umbilical arterial pH ≤7.00, and clinical exam findings concerning for hypoxic–ischemic encephalopathy (HIE). Initial stabilization occurs in the delivery room and neonatal intensive care unit (NICU) with airway support, mechanical ventilation as needed, and hemodynamic optimization. After multidisciplinary review of selection criteria (gestational age ≥36 weeks, evidence of moderate to severe encephalopathy, and meeting timing criteria within 6 hours of birth), the attending neonatologist initiates controlled therapeutic hypothermia.
The clinical workflow includes placement of continuous core temperature monitoring using an esophageal probe, initiation of whole-body cooling to a target core temperature (typically 33.5°C) with servo-controlled cooling system, frequent neurologic examinations, continuous cardiorespiratory monitoring, and serial laboratory assessments (blood gases, electrolytes, coagulation studies). The provider documents the decision-making process, informed consent discussion with the family, temperature monitoring method (esophageal probe), duration of cooling (commonly 72 hours), and daily assessments for complications. Rewarming is performed protocolized with close monitoring. This service is performed in the NICU or regional neonatal intensive care setting by neonatology or pediatric critical care providers experienced in therapeutic hypothermia.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|